ArticleESMO gastrointestinal oncology2026

PROSPER: a phase III trial of lecithinized superoxide dismutase to prevent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.

K Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.